Correction: Toosendanin Demonstrates Promising Antitumor Efficacy in Osteosarcoma by Targeting STAT3

Oncogene - United Kingdom
doi 10.1038/s41388-019-0738-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Lycorine Displays Potent Antitumor Efficacy in Colon Carcinoma by Targeting STAT3

Frontiers in Pharmacology
Pharmacology
2018English

Efficacy of an Anti-Cancer Strategy Targeting SET in Canine Osteosarcoma

Journal of Veterinary Medical Science
Veterinary
2019English

Targeting Stat3 in the Myeloid Compartment Drastically Improves the in Vivo Antitumor Functions of Adoptively Transferred T Cells

Cancer Research
Cancer ResearchOncology
2010English

Targeting Glutaminase1 and Synergizing With Clinical Drugs Achieved More Promising Antitumor Activity on Multiple Myeloma

Oncotarget
Oncology
2019English

MicroRNA-221 Promotes Cisplatin Resistance in Osteosarcoma Cells by Targeting PPP2R2A

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2019English

MALAT1 Promotes Osteosarcoma Development by Targeting TGFA via MIR376A

Oncotarget
Oncology
2016English

Efficacy of Glycogen Synthase Kinase-3β Targeting Against Osteosarcoma via Activation of Β-Catenin

Oncotarget
Oncology
2016English

61PArming Oncolytic Adenovirus With FAP-targeting Bispecific T-Cell Engager to Improve Antitumor Efficacy

Annals of Oncology
MedicineOncologyHematology
2017English

Targeting Constitutively-Activated STAT3 in Hypoxic Ovarian Cancer, Using a Novel STAT3 Inhibitor

Oncoscience
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy